Jo Huiqing Zhou’s team, theme Reconstructive and regenerative medicine, has recently obtained a Van Gogh Program travel grant, together with Professor Daniel Aberdam’s team in INSERM Paris. This travel grant is to facilitate an on-going collaborative project of two teams, on the research topic of ‘epigenetic mechanisms and therapeutic rescue of limbal stem cell deficiency’.
Limbal Stem Cell DeficiencyHuman cornea is constantly renewed by stem cells of the limbus, which is located at the cornea periphery. Degenerative corneal diseases are often caused by Limbal Stem Cell Deficiency (LSCD) that leads to blindness. Inherited LSCD is associated with mutations of PAX6 in aniridia and of p63 in ectodermal dysplasia syndromes. So far the molecular mechanism of LSCD are not fully understood, and no cure is yet available for LSCD. This collaborative project is to combine the complementary expertise of limbal stem cell research in the Aberdam Lab (INSERM, Paris) and of epigenetic characterization of stem cells in the Zhou Lab (Radboud University, Nijmegen) to dissect molecular mechanisms of LSCD and develop therapeutic options. In this project, we will use cellular models of patient derived limbal stem cells and induced pluripotent stem cell that can be differentiated towards limbal epithelial cells.
Related news items
Ignacio Malagon, first professor of Pediatric Anaesthesiology in the Netherlands21 January 2019
Ignacio Malagon has been appointed professor of Pediatric Anaesthesiology at Radboud University / Radboud university medical center with effect from 1 January 2019. He is the first professor in this field in the Netherlands.read more
Quickly detecting actual heart attacks prevents unnecessary hospital visits Research by Radboud university medical center improves efficacy and reduces cost of cardiac care4 January 2019
Many patients who suffer from chest pain are not actually having a heart attack, making an emergency hospital visit unnecessary. Is there a way to quickly and accurately determine at home whether emergency hospital treatment is necessary?read more
Radboud university medical center treats metastatic liver cancer with holmium microspheres MRI imaging during surgery can improve the outcome4 January 2019
For the first time Radboud university medical center has treated a patient with liver metastases by using holmium radio-embolization. With this technique, radioactive holmium microspheres are injected via a catheter into the liver artery.read more
Research into drugs for treating rare diseases can be more efficient and patient-oriented18 December 2018
To assess whether a drug is an effective treatment for a rare disease, large-scale research with Randomized Controlled Trials may not be necessary in all situations, say researchers from the departments of Neurology and Health Evidence in the Journal of the American Medical Association (JAMA).read more